Form 4: Artiva Biotherapeutics Executive Sells Shares
Insider Transaction (Form 4)
Jennifer Bush, COO, CLO, Compliance Officer of Artiva Biotherapeutics, Inc., sold 8,391 shares of common stock on September 3, 2026 for $11.16 per share.
Summary
- Open-market sale: disposed of 8,391 Common Stock at $11.16 ($93,606) on September 3, 2026; holds 329,529 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $93,606 of stock on the open market.
Insider Transactions
Jennifer Bush — Officer (COO, CLO, Compliance Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market sale | Common Stock | 8,391 | $11 | $93.6K | 329,529 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market sale (8,391 shares) |
Keywords
insider transaction, Form 4, ARTV, Artiva Biotherapeutics, Inc., bearish, Jennifer Bush
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.